医学
阶段(地层学)
腺癌
肺
放射科
内科学
肿瘤科
放射性武器
癌症
生物
古生物学
作者
Yanyan Zhang,Fengnian Zhao,Minghao Wu,Yunqing Zhao,Ying Liu,Qian Li,Guiming Zhou,Zhaoxiang Ye
标识
DOI:10.1016/j.ejrad.2021.109802
摘要
Abstract Objectives To retrospectively investigate whether radiological and clinicopathological characteristics were associated with the presence of stage IA–IIA lung adenocarcinoma in patients at high risk for a postoperative recurrence. Materials and Methods Three hundred twelve patients with biopsy-proven node-negative early-stage (IA–IIA) lung adenocarcinoma met the inclusion criteria for this study. Demographics data and histopathological findings were collected from medical records. Computed tomography (CT) performed approximately 1 month before surgery was manually scored using 23 CT descriptors. Univariate analyses were applied to demonstrate an association between clinicopathological and radiological features and 2-/5-year recurrences. Multivariate logistic regression was performed to assess the ability of radiological and clinicopathological features to discriminate low and high-risk factors for recurrence. A ROC curve was used to evaluate prediction performance. Results Univariate analysis revealed that the 2-year recurrence was associated with six radiological features and two clinicopathological features, while 5-year recurrence was associated with five radiological features and two clinicopathological features. A multivariate logistic regression model of combined clinicopathological and radiological features showed that stage IIA (OR = 2.87), solid texture (solid part > 50 %: OR = 4.81; solid part = 100 %: OR = 3.61), pleural attachment (OR = 3.97) and bronchovascular bundle thickening (OR = 2.16) were associated with the independent predictors of 2-year recurrence, and stage IIA (OR = 3.52), solid texture (solid part > 50 %: OR = 3.56; solid part = 100 %: OR = 2.44) and pleural attachment (OR = 4.57) were associated with 5-year recurrence. Combined radiological and clinicopathological features could be significant indicators of 2- and 5-year recurrences (AUC = 0.784 and AUC = 0.815, respectively). Conclusions The combination of radiological and clinicopathological features has the potential to help predict postoperative recurrence in patients with stage IA–IIA lung adenocarcinomas and guide oncologists and patients whether to undergo additional treatment after surgery.
科研通智能强力驱动
Strongly Powered by AbleSci AI